Cargando…
HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer
Pancreatic cancer is one of the most aggressive solid malignancies prone to metastasis. Epithelial-mesenchymal transition (EMT) contributes to cancer invasiveness and drug resistance. In this study, we investigated whether HS-173, a novel PI3K inhibitor blocked the process of EMT in pancreatic cance...
Autores principales: | Rumman, Marufa, Jung, Kyung Hee, Fang, Zhenghuan, Yan, Hong Hua, Son, Mi Kwon, Kim, Soo Jung, Kim, Juyoung, Park, Jung Hee, Lim, Joo Han, Hong, Sungwoo, Hong, Soon-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363641/ https://www.ncbi.nlm.nih.gov/pubmed/27793006 http://dx.doi.org/10.18632/oncotarget.12871 |
Ejemplares similares
-
Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer
por: Park, Jung Hee, et al.
Publicado: (2017) -
HS-173, a Novel PI3K Inhibitor, Attenuates the Activation of Hepatic Stellate Cells in Liver Fibrosis
por: Son, Mi Kwon, et al.
Publicado: (2013) -
HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation
por: Kim, Soo Jung, et al.
Publicado: (2014) -
Crizotinib Exhibits Antitumor Activity by Targeting ALK Signaling not c-MET in Pancreatic Cancer
por: Yan, Hong Hua, et al.
Publicado: (2014) -
PBT-6, a Novel PI3KC2γ Inhibitor in Rheumatoid Arthritis
por: Kim, Juyoung, et al.
Publicado: (2020)